Clinical Trials for Can-Fite BioPharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Can-Fite BioPharma

Clinical Trials (4)

NCT06643260
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
PHASE3Not yet recruiting
705 participants
Started: Jun 30, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor0 locations
NCT06387342
Namodenoson Treatment of Advanced Pancreatic Cancer
PHASE2Recruiting
20 participants
Started: Nov 10, 2024 · Completed: Dec 15, 2026
2 conditions1 sponsor1 location
NCT05201404
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
PHASE3Recruiting
471 participants
Started: Mar 15, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor32 locations
NCT04697810
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
PHASE2Recruiting
114 participants
Started: Dec 10, 2021 · Completed: Oct 15, 2025
1 condition1 sponsor24 locations